Plasmablastic Lymphoma
Differential Diagnosis
- Immunoblastic diffuse large B cell lymphoma
- ALK positive diffuse large B cell lymphoma
- Primary effusion lymphoma
- Anaplastic (plasmablastic) plasmacytoma
- KSHV-associated germinotropic lymphoproliferative disorder
| Plasmablastic Lymphoma | Immunoblastic DLBCL |
|---|---|
| Typically oral cavity mass in HIV+ patient | Wide variety of presentations, including HIV |
| LCA negative or minimal + | LCA >90% |
| CD20 minimal to negative, CD79a positive | Both CD20 and CD79a >90% |
| Ki67 >95% | Ki67 moderately high, variable |
| EBV in situ 50% | EBV in situ rare in de novo cases; frequent in immunodeficiency cases |
| CD138 positive | CD138 negative |
| Plasmablastic Lymphoma | Primary Effusion Lymphoma |
|---|---|
| Not body cavity based (frequently oral cavity) | Involves body cavity |
| CD45RB weak to negative | CD45RB positive |
| HHV8 only if associated with Castleman disease | HHV8 positive |
Both entities share cytologic features and may also be CD20 and CD45RB negative or minimally reactive
| Plasmablastic Lymphoma | ALK Positive DLBCL |
|---|---|
| Typically oral cavity mass in HIV+ patient | Wide variety of presentations |
| ALK negative | ALK positive |
| CD79a positive | CD79a negative |
| CD138 positive | CD138 negative |
| Plasmablastic Lymphoma | Anaplastic (Plasmablastic) Plasmacytoma/Myeloma |
|---|---|
| Plasmablastic morphology | Subset plasmablastic |
| Often HIV+ or otherwise immunosuppressed | Usually not immunosuppressed |
| Often in oral cavity or mucosal areas of head | Extraosseous sites overlap |
| ~60% EBV+ | usually EBV negative |
| Plasmablastic Lymphoma | KSHV-associated Germinotropic Lymphoproliferative Disorder |
|---|---|
| Typically oral cavity | Localized lymphadenopathy |
| Immunosupressed patient | Immunocompetent patient |
| Sheets of plasmablasts | Plasmablasts involve germinal centers |
| Some cases associated with multicentric Castleman disease (MCD) | No Castleman features in follicles |
| EBV 50% positive | EBV positve |

